ERBB2 and breast neoplasm: Our work here indicates that single-cell, multiplexed IF imaging may be a reliable approach to elucidate both HER2 and tumor ITH in research settings and provides a basis for testing multiplexed platforms for assessing ITH in breast tumors in clinical settings.